Literature DB >> 2917786

Immunoprophylaxis of Chlamydia trachomatis lymphogranuloma venereum pneumonitis in mice by oral immunization.

Z D Cui1, L J LaScolea, J Fisher, P L Ogra.   

Abstract

Groups of BALB/c mice were orally immunized with chlamydiae and challenged intranasally to determine whether oral immunization offers protection against pulmonary disease and to characterize the nature and kinetics of the chlamydial antibody response in the lung and other mucosal sites. Protection by oral immunization from chlamydial lung disease was demonstrated by lack of replication of the organism and the lack of chlamydial antigen in lung tissue. The chlamydial immunoglobulin A (IgA) antibody response was present at all body sites, reaching peak levels in the lung as well as in the serum. Classical IgA booster effect kinetics was observed after intranasal challenge, especially in the lung. Specific IgG antibody was detected at all body sites but at lower levels. Furthermore, animals immunized orally had no pneumonic process, as determined by histopathology. These studies also suggest that passively acquired specific serum IgG antibody may not significantly influence the course of mucosal replication of the organism. These observations indicate that oral immunization activating the gut-associated lymphoid tissue system gave total protection against chlamydial lung disease, suggesting migration of immunologically competent cells from the intestine to the lung.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2917786      PMCID: PMC313171          DOI: 10.1128/iai.57.3.739-744.1989

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  19 in total

1.  Isolation of Chlamydia trachomatis from the male urethra.

Authors:  M D Alani; S Darougar; D C Burns; R N Thin; H Dunn
Journal:  Br J Vener Dis       Date:  1977-04

Review 2.  Chlamydial infections (third of three parts).

Authors:  J Schachter
Journal:  N Engl J Med       Date:  1978-03-09       Impact factor: 91.245

3.  Immunity to chlamydial infections of the eye. I. The role of circulatory and secretory antibodies in resistance to reinfection with guinea pig inclusion conjunctivitis.

Authors:  E S Murray; L T Charbonnet; A B MacDonald
Journal:  J Immunol       Date:  1973-06       Impact factor: 5.422

Review 4.  The host spectrum of psittacosis-lymphogranuloma venereum (PL) agents.

Authors:  K F Meyer
Journal:  Am J Ophthalmol       Date:  1967-05       Impact factor: 5.258

5.  Fifteen-month follow-up study of women infected with Chlamydia trachomatis.

Authors:  W M McCormack; S Alpert; D E McComb; R L Nichols; D Z Semine; S H Zinner
Journal:  N Engl J Med       Date:  1979-01-18       Impact factor: 91.245

6.  Chlamydial pneumonia in infants.

Authors:  M R Hammerschlag
Journal:  N Engl J Med       Date:  1978-05-11       Impact factor: 91.245

7.  Animal model studies of genital chlamydial infections. Immunity to re-infection with guinea-pig inclusion conjunctivitis agent in the urethra and eye of male guinea-pigs.

Authors:  L V Howard; M P O'Leary; R L Nichols
Journal:  Br J Vener Dis       Date:  1976-08

8.  Immunity to vaginal reinfection in female guinea pigs infected sexually with Chlamydia of guinea pig inclusion conjunctivitis.

Authors:  H C Lamont; D Z Semine; C Leveille; R L Nichols
Journal:  Infect Immun       Date:  1978-03       Impact factor: 3.441

9.  Chlamydia trachomatis in women: antibody in cervical secretions as a possible indicator of genital infection.

Authors:  D E McComb; R L Nichols; D Z Semine; J R Evrard; S Alpert; V A Crockett; B Rosner; S H Zinner; W M McCormack
Journal:  J Infect Dis       Date:  1979-06       Impact factor: 5.226

10.  Use of enteric vaccines in protection against chlamydial infections of the genital tract and the eye of guinea pigs.

Authors:  R L Nichols; E S Murray; P E Nisson
Journal:  J Infect Dis       Date:  1978-12       Impact factor: 5.226

View more
  6 in total

1.  Chlamydial colonization of multiple mucosae following infection by any mucosal route.

Authors:  L L Perry; S Hughes
Journal:  Infect Immun       Date:  1999-07       Impact factor: 3.441

Review 2.  Mucosal immunity: overcoming the barrier for induction of proximal responses.

Authors:  Brent S McKenzie; Jamie L Brady; Andrew M Lew
Journal:  Immunol Res       Date:  2004       Impact factor: 2.829

3.  Induction of antibody response to Chlamydia trachomatis in the genital tract by oral immunization.

Authors:  Z D Cui; D Tristram; L J LaScolea; T Kwiatkowski; S Kopti; P L Ogra
Journal:  Infect Immun       Date:  1991-04       Impact factor: 3.441

4.  Protection of sheep against Chlamydia psittaci infection with a subcellular vaccine containing the major outer membrane protein.

Authors:  T W Tan; A J Herring; I E Anderson; G E Jones
Journal:  Infect Immun       Date:  1990-09       Impact factor: 3.441

5.  Protection against infertility in a BALB/c mouse salpingitis model by intranasal immunization with the mouse pneumonitis biovar of Chlamydia trachomatis.

Authors:  S Pal; T J Fielder; E M Peterson; L M de la Maza
Journal:  Infect Immun       Date:  1994-08       Impact factor: 3.441

6.  Chlamydia keratoconjunctivitis determination of Chlamydia trachomatis specific secretory immunoglobulin A in tears by enzyme immunoassay.

Authors:  N J Buisman; J M Ossewaarde; M Rieffe; A M van Loon; J S Stilma
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1992       Impact factor: 3.117

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.